FILTER RESULTS
FILTER RESULTS
close.svg
Search Result for “endemic”

Showing 1 - 10 of 64

OPINION

Baht bets rising

Oped, Postbag, Published on 15/12/2025

» Re: "BoT measures to halt rapid baht uptick", (Business, Dec 5). 

OPINION

UN picks rights council members with bad records

Oped, John J Metzler, Published on 23/10/2025

» In a ritual of near-farcical folly, the UN General Assembly has elected 14 new members to join the Geneva-based Human Rights Council on Oct 15.

OPINION

Behind the smiles

Oped, Postbag, Published on 23/09/2025

» Re: "Govt denies seizing BBC footage", (BP, Sept 19). 

OPINION

Challenging Asean digital sovereignty

Oped, Kavi Chongkittavorn, Published on 16/09/2025

» Members of the Association of Southeast Asian Nations (Asean) are busy finalising a draft of a Digital Economic Framework Agreement (Defa) -- this digital framework is hoped to boost regional bloc intra-trade, attract foreign investment, and transform the grouping into a global digital hub. As the current chair, Malaysia is eager to see the world's first such agreement concluded under its leadership.

OPINION

Sustaining healthcare in volatile times

Oped, Vitit Muntarbhorn, Published on 18/08/2025

» Health care is pivotal for human well-being. Yet in today's precarious world, it is pressured by diminishing resources, demographic variables, warfare and violence, and environmental degradation. Sustaining health care thus requires insightful planning and implementation, no less for Thailand and the Association of Southeast Asian Nations (Asean) regions.

OPINION

Curse of casinos

Oped, Postbag, Published on 09/05/2025

» Re: "Senate to invite PM to explain casino-entertainment complex bill", (BP, May 8).

OPINION

Unite to solve neglected diseases

Oped, Muhammad Radzi Abu Hassan, Published on 29/04/2025

» The successful collaboration between the health ministries of Malaysia and Thailand, industry partners in Egypt and Malaysia, and the Drugs for Neglected Diseases initiative (DNDi) to bring a new hepatitis C antiviral drug -- ravidasvir -- to market in 2022 was an important milestone. For years, a 12-week course of treatment using sofosbuvir cost between $70,000 (2.34 million baht) and $80,000, putting it out of reach for many in the Global South. But ravidasvir -- a safe and effective alternative when combined with sofosbuvir -- costs far less, averaging less than $500 per course.

OPINION

Sudan's hell of devastation and despair

Oped, John J. Metzler, Published on 24/04/2025

» The Four Horsemen of the Apocalypse are stalking Sudan: brutal civil conflict, widespread devastation, humanitarian disasters, and the displacement of millions of refugees. Now add the Fifth Horseman, the darkness of global indifference.

OPINION

Protecting the rot

Oped, Postbag, Published on 18/02/2025

» Re: "Corruption still a problem", (Editorial, Feb 15).

OPINION

The missiles of November are too little, too late

Oped, John J. Metzler, Published on 29/11/2024

» There's a strange unease in Europe. Part of it reflects the misplaced nervousness reacting to Donald Trump's re-election as the US President. Naturally there's the predictable political nail biting that a new virulent and assertive US administration will be tough on European trade deficits as well as not instinctively committed to writing blank checks for Ukrainian military aid. The wider issue concerns Ukraine's future and the crescendo of military escalation on both sides to step up, or decisively wind up the war before the end of the lame duck Biden administration.